Johnson & Johnson header image

Johnson & Johnson

JNJ

Equity

ISIN null / Valor 943981

New York Stock Exchange, Inc (2026-11-05)
USD 279.11+1.01%

Johnson & Johnson
UMushroom community rating:

star star star star star
4.21 58 votes No rating yet
NegativeNeutralPositive

About company

Johnson & Johnson is a diversified global healthcare company headquartered in New Brunswick, N.J., that, after spinning off its consumer‑health brands into Kenvue in 2023, is primarily organized around pharmaceuticals (Janssen) and medical devices. Its pharmaceutical business develops and commercializes prescription drugs and biologics across areas such as immunology, oncology, infectious disease and neuroscience, while its medtech operations supply a broad range of hospital and clinic products — including orthopedics, surgery, interventional solutions and vision care — sold through commercial and institutional channels worldwide. The company combines internal R&D with partnerships and acquisitions to advance its pipeline, operates global manufacturing and distribution networks, and is subject to the regulatory, reimbursement and litigation risks typical for large health‑care manufacturers.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

47.9%1Y
82.6%3Y
67.9%5Y

Performance

20.6%1Y
18.6%3Y
18.0%5Y

Volatility

Market cap

665135 M

Market cap (USD)

Daily traded volume (Shares)

9,622,177

Daily traded volume (Shares)

1 day high/low

144.88 / 142.96

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.21

58 votes
Performance:
starstarstarstarstar
4.05
Innovation:
starstarstarstarstar
3.83
Society:
starstarstarstarstar
3.84
Nature:
starstarstarstarstar
3.65
William Phillips
UK, 04 Nov 2026
star star star star star
.
Aleksandr Babkin
UK, 04 Nov 2026
star star star star star
-
Aaditya Sankhwal
UK, 03 Nov 2026
star star star star star
Healthcare compounder back in form: Q3 sales +5.9% to $25.4bn, 2026 guide raised to $101bn (first $100bn year), R&D up 27%. A $5.5bn deal should end 15 years of talc suits. Shares near record after a ~57% 1-yr gain, so valuation is rich. Watch Stelara erosion, MedTech.

EQUITIES OF THE SAME SECTOR

Alcon Inc.
Alcon Inc. Alcon Inc. Valor: 43249246
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.75%CHF 63.28
AEVIS VICTORIA SA
AEVIS VICTORIA SA AEVIS VICTORIA SA Valor: 47863410
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.35%CHF 14.30
Basilea Pharmaceutica Ltd, Allschwil
Basilea Pharmaceutica Ltd, Allschwil Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.96%CHF 73.70
DocMorris Ltd
DocMorris Ltd DocMorris Ltd Valor: 4261528
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.07%CHF 16.24
Omnicell Inc
Omnicell Inc Omnicell Inc Valor: 1275961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
11.14%USD 39.41
L'Oreal S.A.
L'Oreal S.A. L'Oreal S.A. Valor: 502805
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.78%EUR 444.75
Sanofi SA
Sanofi SA Sanofi SA Valor: 699381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.85%EUR 84.10
Ipsen
Ipsen Ipsen Valor: 2348805
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.70%EUR 155.80
Ramsay Generale de Sante SA
Ramsay Generale de Sante SA Ramsay Generale de Sante SA Valor: 1247709
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.37%EUR 8.62
Siemens Healthineers AG
Siemens Healthineers AG Siemens Healthineers AG Valor: 40652181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.46%EUR 44.85